• Therapeutics
  • Protein Discovery
  • Technologies
  • Diagnostics
  • Partner

  • Resources

    Reading and writing the code of life

    • Publications

      Learn more about our technology

    • Newsroom

      Keep up with our latest news

  • Company

    Reading and writing the code of life

    • About

      Learn more about us

    • Careers

      We’re hiring!

    • Contact

      Get in touch with us

  • We’re hiring

Genome Editing

  • All
  • Uncategorized
  • CRISPR DX
  • CRISPR Portfolio
  • Interviews
  • Miscellaneous
  • Genome Editing
  • DEI
  • 06/10/2022

    Podcast – Biotech 2050 interviews Mammoth Co-Founder and CEO Trevor Martin

    Learn More
  • 04/07/2022

    Why is the liver a popular target for therapeutic genome editing?

    Learn More
  • 01/20/2022

    Knocking out, writing, and modulating DNA with CRISPR

    Learn More
  • 11/04/2021

    Using CRISPR to overcome the challenges of in vivo genome editing

    Learn More
  • 07/20/2021

    Cell therapies and ex vivo genome editing

    Learn More
  • 06/08/2021

    A broad overview of CRISPR delivery methods

    Learn More
  • 04/28/2021

    Important factors to consider in CRISPR delivery

    Learn More
  • 03/09/2021

    Cas9 Immunity

    Learn More
  • 10/19/2020

    Expanding the possibilities of CRISPR genome editing with Cas14 and CasΦ

    Learn More
  • Posts navigation

    1 2 Next

Mammoth Biosciences, Inc.
1000 Marina Blvd.
Brisbane, CA 94005

info@mammothbiosci.com © 2024 Mammoth Biosciences, Inc. | Privacy Policy | Terms of Use